Androgen loss accelerates brain tumor growth via HPA axis activation

Mechanism of Tumor Acceleration

Research published in the journal Nature has identified a biological mechanism by which the loss of androgen hormones, such as testosterone, accelerates the growth of brain tumors in males. The study utilized a preclinical model of glioblastoma to demonstrate that androgen deficiency drives tumor progression by inducing local inflammation and triggering the hypothalamus-pituitary-adrenal (HPA) axis.

According to the findings, the activity of the HPA axis increased in castrated mice, with this effect being particularly pronounced in those that had brain tumors. The researchers identified that the HPA axis is likely triggered by inflammation in the hypothalamus caused by the tumors in these androgen-deficient mice.

Role of Inflammation and Immunity

The study further detailed the specific drivers of this hormonal response. Researchers identified the elevated production of proinflammatory cytokines, specifically IL-1β and TNF, in the brains of castrated mice as a primary driver of HPA axis activation.

These findings reveal unique endocrine-mediated mechanisms through which brain tumors modulate systemic immunity when androgens are deprived. The research highlights the importance of organ-specific effects on anti-tumor immunity, noting that androgen loss weakens the body's ability to fight the tumor.

Comparative Tumor Growth

The research noted a distinction in how androgen loss affected tumors based on their location in the body. While the loss of androgens accelerated the growth of tumors located within the brain, the effect was different when tumors were located outside the brain.

Androgens are steroid hormones that typically stimulate or control the development of masculine characteristics by binding to androgen receptors. While some hormones are thought to suppress anti-tumor T cell immunity and promote progression, this study reports a previously unknown interaction regarding the HPA axis and brain tumor growth.

Future Research Directions

The study was funded by the National Institutes of Health (NIH). Following these results, researchers intend to conduct further work to determine exactly how tumors induce the HPA axis reaction in a region of the brain that is entirely separate from the tumor site.